APOE and fatty liver disease: In summary, our present study shows that ISL, a bioactive ingredient of flavonoids, reduces plasma VLDL/LDL, improves HDL function and plasma redox status, and suppresses macrophage and liver inflammation, resulting in reduced atherosclerotic plaque development and diminished hepatic steatosis in Western diet-fed apoE−/− mice.